No CrossRef data available.
Article contents
Intravenous amino acid supplementation reduces 28-d mortality in sepsis: a retrospective cohort study from Medical Information Mart for Intensive Care-IV database and Mendelian randomisation analysis
Published online by Cambridge University Press: 09 February 2026
Abstract
Sepsis-related deaths remain prevalent in intensive care settings, with metabolic dysregulation as a key contributor. Although amino acid supplementation has shown promise, its clinical effectiveness in sepsis is unclear. This study evaluated the impact of intravenous amino acid administration on 28-d mortality in intensive care unit (ICU) sepsis patients using retrospective cohort analysis and Mendelian randomisation (MR). We analysed data from the Medical Information Mart for Intensive Care-IV database, matching 726 patients (363 per group) using propensity scores. The association between amino acid supplementation and mortality was assessed using logistic regression, Cox regression and targeted maximum likelihood estimation (TMLE). Two-sample MR was used to explore causal links between twenty common amino acids and sepsis mortality. In the cohort analysis, amino acid supplementation was consistently associated with significantly reduced 28-d mortality across all analytical methods (logistic regression: OR = 0·48, P < 0·01; Cox regression: HR = 0·48, P < 0·01; TMLE: average treatment effect = −0·102, P < 0·01). In contrast, the MR analysis did not find a significant causal association for any single amino acid after correction for multiple comparisons; although glycine showed a nominal protective signal, it did not remain significant after false discovery rate correction. This dual-method study demonstrates a strong association between compound amino acid infusions and reduced mortality in sepsis but did not identify any single amino acid as a robust causal mediator. These findings suggest the benefit may arise from a synergistic effect, highlighting the need for randomised controlled trials to validate these observational results and optimise nutritional strategies.
Information
- Type
- Research Article
- Information
- Copyright
- © The Author(s), 2026. Published by Cambridge University Press on behalf of The Nutrition Society
References
Singer, M, Deutschman, CS, Seymour, CW, et al. (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315, 801–810.Google Scholar
Hsu, CC, Sun, CY, Tsai, CY, et al. (2021) Metabolism of proteins and amino acids in critical illness: from physiological alterations to relevant clinical practice. J Multidisciplinary Healthcare 14, 1107–1117.Google Scholar
Doig, GS, Simpson, F, Bellomo, R, et al. (2015) Intravenous amino acid therapy for kidney function in critically ill patients: a randomized controlled trial. Intensive Care Med 41, 1197–1208.Google Scholar
Bonvini, A, Coqueiro, AY, Tirapegui, J, et al. (2018) Immunomodulatory role of branched-chain amino acids. Nutr Rev 76, 840–856.Google Scholar
Mattick, JSA, Kamisoglu, K, Ierapetritou, MG, et al. (2013) Branched-chain amino acid supplementation: impact on signaling and relevance to critical illness. Wiley Interdiscip Rev Syst Biol Med 5, 449–460.Google Scholar
Morris, CR, Hamilton-Reeves, J, Martindale, RG, et al. (2017) Acquired amino acid deficiencies: a focus on arginine and glutamine. Nutr Clin Pract: Offic Publ Am Soc Parenteral Enteral Nutr 32, 30s–47s.Google Scholar
Jaurila, H, Koivukangas, V, Koskela, M, et al. (2020) 1H NMR based metabolomics in human sepsis and healthy serum. Metabolites 10, 70.Google Scholar
Heming, N, Carlier, R, Prigent, H, et al. (2022) Effect of an enteral amino acid blend on muscle and gut functionality in critically ill patients: a proof-of-concept randomized controlled trial. Crit Care 26, 358.Google Scholar
Reisinger, AC, Posch, F, Hackl, G, et al. (2021) Branched-chain amino acids can predict mortality in ICU sepsis patients. Nutrients 13, 3106.Google Scholar
Reizine, F, Gregoire, M, Lesouhaitier, M, et al. (2022) Beneficial effects of citrulline enteral administration on sepsis-induced T cell mitochondrial dysfunction. Proc Natl Acad Sci USA 119, e2115139119.Google Scholar
Hou, YC, Wu, JM, Chen, KY, et al. (2023) Glutamine and leucine administration attenuates muscle atrophy in sepsis. Life Sci 314, 121327.Google Scholar
Tadie, JM, Locher, C, Maamar, A, et al. (2023) Enteral citrulline supplementation v. placebo on SOFA score on day 7 in mechanically ventilated critically ill patients: the IMMUNOCITRE randomized clinical trial. Crit Care 27, 381.Google Scholar
Luiking, YC, Poeze, M & Deutz, NE (2020) A randomized-controlled trial of arginine infusion in severe sepsis on microcirculation and metabolism. Clin Nutr 39, 1764–1773.Google Scholar
Resche-Rigon, M & White, IR (2018) Multiple imputation by chained equations for systematically and sporadically missing multilevel data. Stat Methods Med Res 27, 1634–1649.Google Scholar
Shin, SY, Fauman, EB, Petersen, AK, et al. (2014) An atlas of genetic influences on human blood metabolites. Nat Genet 46, 543–550.Google Scholar
Kettunen, J, Demirkan, A, Würtz, P, et al. (2016) Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA. Nat Commun 7, 11122.Google Scholar
Heyland, D, Muscedere, J, Wischmeyer, PE, et al. (2013) A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 368, 1489–1497.Google Scholar
Marik, PE & Zaloga, GP (2008) Immunonutrition in critically ill patients: a systematic review and analysis of the literature. Intensive Care Med 34, 1980–1990.Google Scholar
Mosevoll, KA, Hansen, BA, Gundersen, IM, et al. (2023) Systemic metabolomic profiles in adult patients with bacterial sepsis: characterization of patient heterogeneity at the time of diagnosis. Biomolecules 13, 223.Google Scholar
Spanaki, AM, Tavladaki, T, Dimitriou, H, et al. (2018) Longitudinal profiles of metabolism and bioenergetics associated with innate immune hormonal inflammatory responses and amino-acid kinetics in severe sepsis and systemic inflammatory response syndrome in children. JPEN J Parenteral Enteral Nutr 42, 1061–1074.Google Scholar
Su, L, Li, H, Xie, A, et al. (2015) Dynamic changes in amino acid concentration profiles in patients with sepsis. PloS one 10, e0121933.Google Scholar
Druml, W, Heinzel, G & Kleinberger, G (2001) Amino acid kinetics in patients with sepsis. Am J Clin Nutr 73, 908–913.Google Scholar
García-de-Lorenzo, A, Ortíz-Leyba, C, Planas, M, et al. (1997) Parenteral administration of different amounts of branch-chain amino acids in septic patients: clinical and metabolic aspects. Crit Care Med 25, 418–424.Google Scholar
Landoni, G, Monaco, F, Ti, LK, et al. (2024) A randomized trial of intravenous amino acids for kidney protection. N Engl J Med 391, 687–698.Google Scholar
Zhu, R, Allingstrup, MJ, Perner, A, et al. (2018) The effect of IV amino acid supplementation on mortality in ICU patients may be dependent on kidney function: post hoc subgroup analyses of a multicenter randomized trial. Crit Care Med 46, 1293–1301.Google Scholar
Wang et al. supplementary material 1
Wang et al. supplementary material
File
366 KB
Wang et al. supplementary material 2
Wang et al. supplementary material
File
17.8 KB
Wang et al. supplementary material 3
Wang et al. supplementary material
File
16.4 KB